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Abstract
Sparse-data problems are common, and approaches are needed to evaluate the sensitivity of 
parameter estimates based on sparse data. We propose a Bayesian approach that uses weakly 
informative priors to quantify sensitivity of parameters to sparse data. The weakly informative 
prior is based on accumulated evidence regarding the expected magnitude of relationships using 
relative measures of disease association. We illustrate the use of weakly informative priors with an 
example of the association of lifetime alcohol consumption and head and neck cancer. When data 
are sparse and the observed information is weak, a weakly informative prior will shrink parameter 
estimates toward the prior mean. Additionally, the example shows that when data are not sparse 
and the observed information is not weak, a weakly informative prior is not influential. 
Advancements in implementation of Markov Chain Monte Carlo simulation make this sensitivity 
analysis easily accessible to the practicing epidemiologist.
Epidemiologic studies often must cope with sparse-data problems due to small sample sizes 
or to reduction in effective sample size due to the study of very uncommon (or common) 
exposures1 or highly correlated variables.2 However, determining the presence and impact 
of sparse data in a given study is not as clear as one might believe. In studies with only a few 
categorical variables, the researcher may be able to identify the presence of sparse data by 
observing the sample size within cells of contingency tables.3 However, as data become 
more complex, this approach becomes untenable. In a regression model with a large number 
of covariates, researchers should be concerned about the potential impact of data sparseness. 
One way to quantify the impact of sparse data on parameter estimates is with a sensitivity 
analysis in which the observed data are augmented with a small amount of additional data 
(for instance, a few additional exposed cases and controls). Quantifying the degree of 
change in the parameter estimates that results from the addition of a small amount of 
additional information represents an informal assessment of the impact of sparse data. If the 
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data are sparse, model estimates will be sensitive to this additional information. If the data 
are not sparse, model estimates will be robust to the added information.
A method for testing the sensitivity of particular model parameters to sparse data is a natural 
complement to existing methods for evaluating systematic errors due to confounding, 
measurement error, and selection bias.4–7 Augmenting the observed data with a small 
amount of additional information is easily accomplished with Bayesian analysis. To this 
end, we propose the use of a weakly informative prior. Recent advancements in Markov 
Chain Monte Carlo techniques make this approach easy to use in day-to-day regression 
analyses. We provide two examples (one as an eAppendix, http://links.lww.com/EDE/A650) 
of odds ratios obtained from conditional logistic regression models, which are notoriously 
susceptible to sparse-data problems.
WEAKLY INFORMATIVE PRIORS
Inclusion of a prior in a regression model is a simple means of representing the body of 
knowledge for a parameter of interest external to the study that generated the data.8,9 The 
degree of support for this belief is inversely related to the variance of the prior; that is, the 
smaller the variance, the more support for the prior. In epidemiologic analyses, researchers 
may have a priori beliefs that large effect estimates of an exposure–outcome relationship are 
very unlikely. In studies of common exposures or widespread environmental pollutants, this 
belief is well-founded, as it is exceedingly rare to see relative measures of effect greater than 
10 or less than 1/10. Indeed, outside of a few areas such as infectious disease, exposures are 
unlikely to be highly associated with the outcome.10 As regression models become more 
complex, it is increasingly difficult to determine whether large effects are based on a reliable 
amount of information within the data or result from problems of data sparseness. Standard 
maximum likelihood estimators are not well suited for analyses of sparse or highly 
correlated data. Maximum likelihood estimation relies on asymptotic theory, which typically 
guarantees that estimators are unbiased with an infinite sample size. However, with small 
sample sizes these estimators may be highly biased.3 Despite the fact that conditional 
maximum likelihood estimators were developed to deal with sparse data in matched case-
control studies,11,12 they are themselves subject to sparse-data problems, which occur when 
there are a large number of strata defined by matching factors and limited data within these 
strata. This limitation may produce unstable parameter estimates.
Other researchers have shown the utility of correcting for sparse-data problems, and have 
presented techniques such as use of data-augmentation priors.13,14 These priors, which are 
Bayesian in nature, have been applied using maximum likelihood estimators, which rely on 
asymptotic assumptions.15 The use of data-augmentation priors requires a rescaling step to 
improve its asymptotic approximation. This step is unnecessary when implementing a 
weakly informative prior using Markov chain Monte Carlo.3,14,15 Markov Chain Monte 
Carlo methods can be used to incorporate information external to the data; however, with 
current versions of Statistical Analysis Software (SAS), implementing Markov Chain Monte 
Carlo techniques can be easier than traditional data-augmentation approaches.
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This advance in statistical software transforms the evaluation of model-estimate-sensitivity 
into a potentially routine procedure for the practicing epidemiologist. To this end, we 
propose a generic weakly informative prior based on an a priori expectation of the 
magnitude of the relation between an exposure and outcome of interest. For general 
application, we recommend a normally distributed prior for a regression coefficient, β, such 
that mean μ = 0 and variance σ2 = 1.38. In effect, this says that before conducting the 
analysis, we are 95% certain that the relative effect estimate is between 0.1 to 10 on a ratio 
scale, centered at 1.00, or null. To mimic the weight of information contributed by this 
weakly informative prior, one may think of a data-augmentation approach where the 
researcher adds three observations to each cell in a 2 × 2 table: the mean and approximate 
variance of the log odds ratio (obtained using Woolf’s formula) from a 2 × 2 table in which 
all cells contain three observations are 0 and 1.33, respectively.16,17 This variance is 
calculated as follows:
Keeping this in mind, one way to treat the result of a sensitivity analysis using a weakly 
informative prior is the parameter estimate that would have resulted had the investigator 
observed a small amount of additional data that reflected the null hypothesis. In a situation 
where a wealth of previous evidence supports a harmful (or protective) effect of the risk 
factor with the outcome, the null-centered prior can be easily adjusted to reflect this 
knowledge.
A weakly informative prior is a relatively weak statement of prior knowledge and is tenable 
in most epidemiologic settings.18,19 As the sample size of the study increases, a weakly 
informative prior will have vanishing impact on model estimates. Specifically, as data 
become less sparse, we would obtain approximately the same point and interval estimates 
with or without a weakly informative prior. However, in the presence of sparse data, a 
weakly informative prior will help stabilize estimation and shrink the unstable and 
potentially biased maximum likelihood estimates toward the prior mean. We present a 
worked example of calculating odds ratios below, and we provide a second (simpler) 
example (along with data and SAS code) as an electronic supplement.
EXAMPLE: ALCOHOL CONSUMPTION AND ORAL CANCER
Hakenewerth et al20 studied the relationship of alcohol consumption and oral cancer among 
the Carolina Head and Neck Cancer Epidemiology Study, a population-based case-control 
study of squamous cell carcinoma of the head and neck conducted in North Carolina 
between 2002 and 2006. The authors analyzed data on 1227 cases and 1325 controls who 
were frequency-matched on age (25–49, 50–54, 55–59, 60–64, 65–69, 70–74, 75–80 years), 
race (European–American, African–American), and sex, creating 28 matched strata. 
Additionally, the data include information regarding continuous duration of cigarette 
smoking (as total years of smoking), a known confounder of the relationship alcohol 
consumption and oral cancer.21,22 Because this is a frequency-matched case-control design, 
the authors conducted conditional logistic regression analyses where the relationship 
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between lifetime alcohol consumption and oral cancer was evaluated, conditional on race, 
age, and sex and controlling for continuous years of cigarette smoking. Lifetime alcohol 
consumption, in liters (L), is divided into four ordered categories of exposure (0, >0–133, 
>133–758, and >758), and cigarette consumption is treated as continuous. We recreate the 
authors’ original analysis, estimating the odds of head and neck cancer associated with 
alcohol consumption, adjusting for continuous years of cigarette exposure, age, race, and 
sex.
STATISTICAL ANALYSIS
We assume the outcome, yik, for individual i = 1, 2, …, Ik in stratum k = 1, 2, …, K, follows 
a logistic model with stratum-specific intercepts, αk
(1)
where xik is a vector of covariates and β is the vector of coefficients of interest. Under the 
conditional logistic regression approach, estimation of αk is avoided by specifying the 
likelihood of the data conditional on each stratum. Because of the frequency-matched data 
used in this example, the number of cases, n1k, and controls, n0k, in each stratum may vary, 
and a general form of the conditional likelihood can be specified as:
(2)
where the sk is all possible combinations of n1k cases and n0k controls in the kth stratum, 
and dk is a vector of one of the possible combinations with dik, an element in dk.23
A typical frequentist approach to analyzing matched case-control data would involve 
maximizing (2) with respect to β. Implementing our weakly informative prior involves a 
relatively simple extension of the conditional likelihood. The posterior distribution of 
interest is proportional to the conditional likelihood in expression (2) times the weakly 
informative prior. Because our weakly informative prior has the form of independent normal 
priors for the log odds ratios, our posterior distribution is proportional to
(3)
where j = 1 to J indexes the J regression coefficients.
We note that the general form of expression (3) is the same as frequentist procedures that 
penalize the likelihood, such as ridge regression.24 Indeed, the weakly informative prior we 
have specified is a Bayesian analog of ridge regression in which the tuning parameter is 
specified based on prior knowledge.
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We used a Gibbs sampler to run Bayesian models for 10,000 iterations with a burn-in of 
1,000 iterations. A Gelman–Rubin diagnostic check was conducted for three chains to 
confirm convergence of the Markov Chain Monte Carlo procedure. Trace and 
autocorrelation plots indicate model convergence. When reporting results, we provide 95% 
confidence intervals and 95% posterior intervals (PIs) for non-Bayesian and Bayesian 
models, respectively. All analyses were conducted in SAS version 9.2 (SAS Institute, Cary, 
NC).
RESULTS
The Table provides an example of model results that are moderately and highly sensitive to 
sparse data. We highlight the percent change in the odds ratios of oropharyngeal and 
hypopharyngeal cancer for each category of alcohol consumption compared with no alcohol 
consumption. For oropharyngeal cancer, the conditional maximum likelihood estimates are 
moderately precise, suggesting that data are not overly sparse across strata of the matching 
factors. The odds ratios for oropharyngeal cancer associated with low, medium, and high 
levels of lifetime alcohol consumption, relative to none, change by 10%, 6%, and 32%, 
respectively, when a weakly informative prior is incorporated. The precision of the estimates 
is largely unaffected by the weakly informative prior, with the exception of the highest 
category of alcohol exposure, for which the upper bound of the 95% PI is more strongly 
attenuated toward the prior mean. Figure 1 shows the relative contribution to the posterior 
distributions of the odds ratio of oropharyngeal cancer from the weakly informative prior 
and likelihood for each category of alcohol consumption. In these graphs, we overlay plots 
of the weakly informative prior, the likelihood function based on the observed data, and the 
posterior distribution based on Markov Chain Monte Carlo sampling. The observed data 
(summarized in the likelihood) are driving the estimation of the posterior distributions, and 
the weakly informative prior has modest impact on the interpretation of the parameters. 
Only the highest tertile, where the magnitude and precision of the odds ratio change 
moderately, shows evidence of instability due to sparse data.
Unlike oropharyngeal cancer, the confidence intervals for the association of alcohol 
consumption and hypopharyngeal cancer are wide. The odds ratios associated with tertiles of 
lifetime alcohol consumption change by 105%, 114%, and 120%, respectively, when the 
weakly informative prior is implemented. In addition to a large shift in the parameter 
estimates toward the mean of the weakly informative prior, the upper bounds of the 95% PIs 
each show an approximately 10-fold decrease in magnitude, whereas the lower bound of the 
95% PIs are largely unaffected. Figure 2 illustrates the relative contribution of the weakly 
informative prior and likelihood to the posterior distribution of the odds ratio of 
hypopharyngeal cancer. The likelihood and weakly informative prior provide a similar 
contribution to estimation of the posterior distributions, highlighting the extremely sparse 
nature of the available data.
The odds ratio for the lower tertile of alcohol consumption is shifted past the prior mean to a 
value of 0.79 (95% PI = 0.25, 2.61), which is a counterintuitive finding at first glance. This 
is a result of the extremely high correlation between parameters representing the effects of 
the highest and lowest tertiles of alcohol consumption (Pearson r = 0.87). The high 
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correlation implies that if the odds ratio for the highest tertile is shrunk in one direction, the 
odds ratio for the lowest tertile will also be shrunk in that direction, even if the priors are 
independent. The substantial shrinkage of the highest tertile toward smaller values translated 
into additional shrinkage of the lowest tertile toward smaller values—in this case, values 
less than the null. Although the magnitude of these parameter estimates changes 
dramatically, decisions that might be based on statistical cutpoints represented by the 95% 
PI remain unchanged.
DISCUSSION
Quantitative techniques have been developed for post hoc evaluation of sensitivity of model 
parameters based on proposed degrees of confounding, misclassification, or selection 
bias.4,7,25 However, methods are undeveloped for quantifying the influence of adding 
modest information to the data, such as observing a few extra exposed and unexposed cases 
or controls. We have presented a simple approach for quantifying sensitivity of model 
results using a weakly informative prior based on general substantive beliefs about a 
credible range of values for the effect estimate of interest. Although the use of such priors 
has been proposed previously,26–28 limitations in statistical software have been a barrier to 
implementation. Advances in statistical software have now made appropriate tools easily 
accessible; one can incorporate weakly informative priors with the addition of a single line 
of software code (see the eAppendix, http://links.lww.com/EDE/A650 for a simple 
example). Thus, this article also illustrates the relative ease with which analysis can include 
a Bayesian component—a process that was previously quite difficult. Our examples include 
a case where the change in effect estimate is minimal, and another that tempers our 
interpretation of the magnitude of effect.
From a Bayesian perspective, frequentist regression models are often a special case of a 
Bayesian model—one in which a flat prior is specified and all values for a parameter 
estimate of interest are set a priori as equally plausible. However, most epidemiologists 
would not regard all values for parameters representing an exposure–disease relationship of 
interest as equally likely. Belief regarding a plausible range of values may be specific to a 
study of interest, based on the general body of knowledge in a substantive field (as in our 
example), or drawn from research in biology, toxicology, or even physics. It can be useful 
and important to recognize research external to our own, regardless of the source. Our 
weakly informative prior is an example of a simple way to quantitatively formalize this 
generic knowledge and to assess its impact on our results.
To minimize sparse-data problems when studying a specific exposure–disease relationship, 
researchers may attempt to simplify a regression model by systematically removing potential 
effect-measure modifiers or confounders.29,30 In some cases, this may be a reasonable 
approach. However, there are scenarios where model simplification may be untenable. Case-
control studies often include matching designs to improve sampling efficiency, which 
conditions analyses on the matching factors.30 Alternately, a researcher may believe specific 
variables and product terms need to be included in the regression models a priori based on 
substantive knowledge.31–33 In these cases, or when model reduction exercises fail to solve 
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sparse-data problems, an approach to evaluate the sensitivity of a parameter estimate to 
sparse data can be valuable.
As with any analytic tool, a weakly informative prior faces limitations. First, although 
implementing a weakly informative prior with Markov Chain Monte Carlo can be easier 
than data augmentation, it requires familiarity with diagnosing Markov Chain Monte Carlo 
model convergence.34 However, as Markov Chain Monte Carlo becomes more widely used, 
model convergence criteria will become better understood. Second, the strength of any 
informative prior, whether described as weak or strong, is inversely related to the weight of 
information provided by the data and specified regression model. As the data and model 
become more informative, the prior will become less informative. What may be viewed as 
weakly informative in some substantive settings may be viewed as overly informative or 
implausible in others. Therefore, it is important to consider specification of a weakly 
informative prior based on knowledge regarding the expectation of the magnitude, and 
possibly direction, of an etiologic relationship of interest.
Further, attention must be paid to the scale of variables in the model because a sensible 
weakly informative prior may suddenly become nonsensical if the original variable is 
rescaled (eg, if it is divided by 100). As shown in the example, the use of a weakly 
informative prior (or any informative prior) on a single parameter can influence other 
parameters’ estimates if there is high correlation between the parameter and the priors. In 
our example, the shift toward the prior mean for the effect of the highest tertile of alcohol 
consumption drives the estimate of the effect of the lowest category across the prior mean. 
Carlin and Louis35 refer to this as “crossing” and describe its unpredictable occurrence as a 
consequence of integrating prior information into multivariable models. Although this is an 
unexpected result, it serves as a diagnostic check of the robustness of other parameters to 
modest changes to the information within the model. This type of result will often be an 
indication of sparse data as well as of high between-variable correlation. When crossing 
occurs, a research might consider using a weakly informative prior on individual parameters, 
rather than all model parameters.
The example was chosen because the sparseness of data is transparent. In many cases, sparse 
data may not be so obvious, particularly if it occurs in a confounder rather than the main 
exposure. Although good epidemiologic practice typically begins with univariate and 
bivariate descriptions of relevant variables, it may be impossible to examine all contingency 
tables in regression models that contain even moderate numbers of covariates. Further, what 
exactly constitutes sparseness is far from clear. Our weakly informative prior is designed to 
allow researchers to judge the impact of additional modest prior knowledge (or additional 
data) on their findings. Therefore, maximum likelihood estimates in the absence of a weakly 
informative prior should always be presented in addition to posterior estimates that use a 
weakly informative prior. This will also allow the use of the maximum likelihood estimates 
in future meta- or Bayesian analyses. When large-sample theory holds, the maximum 
likelihood estimate will be equal to a Bayesian estimate that uses a noninformative (or 
diffuse) prior for the parameters of interest. In standard epidemiologic regression models, 
such as logistic or log-binomial regression, sparse data can lead to estimates that are far 
from the truth. The use of informative priors, such as our proposed weakly informative prior, 
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for correcting bias is well accepted by both frequentists and Bayesians as a way to 
potentially reduce mean squared error.36,37
The use of a null-centered weakly informative prior is similar to ridge regression, which 
penalizes large parameter estimates in a regression model.38 Other researchers have 
suggested a range of weakly informative priors based on different directions of magnitude, 
such as near the null, moderately positive, or moderately protective.19,27 In addition, 
Spiegelhalter et al39 have advocated for a “skeptical” prior that weights the posterior 
parameter distribution toward a null effect (interpreted in a clinical setting as no difference 
between two treatments). Similar to the Cauchy prior recommended by Gelman et al,26 we 
intend our prior to be broadly applicable by epidemiologists. If the desire is to inform 
parameter estimation with a narrower or broader range of parameter values, an analyst can 
simply adapt the specified variance. Further, it is possible to specify a weakly informative 
prior for some parameters in the data and not others. Specifying a range of weakly 
informative priors will increase the researcher’s understanding of a parameter’s sensitivity to 
the addition of different information, whether it is more or less precise or centered on a 
protective or harmful estimate of the effect. We suggest a range with 95% of the prior mass 
of relative values between 0.1 and 10 as a starting point. However, when more (or less) 
informative priors are supported by evidence in the existing literature, it would be 
recommended to apply them in addition, or as an alternative, to the weakly informative prior 
specified here.
In our example, a reasonable conclusion would be that the parameter estimates are too 
unstable for reliable decision making or inference. If parameter estimates are unchanged 
with a weakly informative prior, one might conclude that the results of the original analysis 
are robust to additional, external information and thus more useful to policy makers. As with 
other sensitivity analyses, the ultimate benefit of a weakly informative prior is to provide a 
better understanding of the strengths and limitations of the data on which decisions or 
inference are based.
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FIGURE 1. 
Kernel density plots for the weakly informative prior (solid line), likelihood (dashed line), 
and posterior (dash-dotted line) for the odds ratio of oropharyngeal cancer associated with 
categories of alcohol consumption represented by β1 (upper), β2 (middle), and β3 (lower).
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FIGURE 2. 
Kernel density plots for the weakly informative prior (solid line), likelihood (dashed line), 
and posterior (dash-dotted line) for the odds ratio of hypopharyngeal cancer associated with 
categories of alcohol consumption represented by β1 (upper), β2 (middle), and β3 (lower).
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TABLE
Association of Lifetime Alcohol Consumption with Head and Neck Cancer
Alcohol Consumption (L) No. Cases/No. Controls
Conditional Maximum 
Likelihood OR (95% CI)
OR Including Weakly 
Informative Prior (95% 
PI)
Change in 
Estimate %
Oropharyngeal cancer
 0 27/280
 >0–133 69/466 0.93 (0.54–1.62) 0.84 (0.53–1.37) 10.2
 134–758 94/360 1.48 (0.83–2.64) 1.40 (0.87–2.27) 5.6
 759+ 120/173 4.49 (2.40–8.39) 3.26 (1.93–5.44) 32.0
Hypopharyngeal cancer
 0 1/280
 >0–133 5/466 2.25 (0.26–19.84) 0.79 (0.25–2.61) 104.7
 134–758 9/360 5.13 (0.61–43.04) 1.64 (0.55–4.91) 114.0
 759+ 36/173 28.74 (3.42–241.40) 8.64 (3.16–26.37) 120.2
PI, Bayesian posterior intervals.
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